Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage
about
The molecular characterization of von Willebrand disease: good in partsWeibel-Palade bodies: a window to von Willebrand disease.New insights into genotype and phenotype of VWD.A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivoClinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand disease.Translational medicine advances in von Willebrand disease.von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.Of von Willebrand factor and platelets.Clinical and laboratory phenotype variability in type 2M von Willebrand disease.A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice.ADAMTS-13 and von Willebrand factor: a dynamic duo.
P2860
Q26996413-8168A9D5-324F-428A-99E3-E8DFBFD88E0DQ27693255-5D06DF11-62D3-4C97-8548-A191F32B2AB6Q36417697-3730BE80-E8F6-41BF-94B5-91F1EB08EA01Q36822738-CBCBCE74-12E6-4CAB-BB66-1EEFB4FAAE90Q36897565-BE37CF8C-D5B4-4283-B7F0-1D67F4D5C155Q36920462-2CFD357E-38C2-4AE0-BB94-013B81CB1561Q37060689-2498A2E4-3191-481F-A5AA-1CA00887E5A1Q37602563-8037C6C2-60F4-441D-A7B1-D6F5B5B525C0Q37635167-C80C2A02-A1E2-4DA5-9138-31BE25AB470DQ38258281-213141E4-95CB-4042-9C66-B87B25CF8892Q45868176-90523FFC-D03B-4DCE-893A-0D2F757F3C0AQ47104681-3B814255-25E8-4594-AFA1-4370913C913FQ48239727-A3BBB281-205C-40B6-B04C-2DD6C910ACA6Q49502949-8DCB003D-8F8B-4809-8469-B0B433EAE937Q50135856-FBB3F8D9-A3D2-4AAE-82F5-0D9473716A97
P2860
Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intersection of mechanisms of ...... ibility, and regulated storage
@ast
Intersection of mechanisms of ...... ibility, and regulated storage
@en
type
label
Intersection of mechanisms of ...... ibility, and regulated storage
@ast
Intersection of mechanisms of ...... ibility, and regulated storage
@en
prefLabel
Intersection of mechanisms of ...... ibility, and regulated storage
@ast
Intersection of mechanisms of ...... ibility, and regulated storage
@en
P2093
P2860
P1433
P1476
Intersection of mechanisms of ...... ibility, and regulated storage
@en
P2093
David A Jakab
Joan Cox Gill
Kenneth D Friedman
Paula M Jacobi
Sandra L Haberichter
Veronica H Flood
P2860
P304
P356
10.1182/BLOOD-2011-06-360875
P407
P577
2012-03-19T00:00:00Z